1)
Shlhub J. 1999. Homocysteine metabolism. Annu RevNutr 19: 217‑246.2)
Ueland PM. 1995. Homocysteine species as components ofplasma redox thiol status. Clin Chem 41: 340‑342.3)
Refsum H, Ueland PM, Nygard 0, Vollset SE. 1998. Homocysteine and cardiovascular disease. Annu RevMed 49: 31‑62.4)
De Bree A, Verschuren WM, Kromhout D,Kluijtmans
LA, Blom HJ. 2002. Homocysteine determinants and the evidence to what extent homocysteine determines the riskof coronary heart disease. Pharmacol Rev 54: 599‑618.5)
Coull BM, Malinow MR, BeamerN, Sexton G, Nordt F, de Garmo P. 1990. Elevated plasmahomocyst(e)ine
concentration as a possible independent risk fTactor for stroke.Stoke 21: 572‑576.
6)
Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg II1, D's Agostino RB, Wilson PW, Wolf PA. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl JMed 346: 476‑483.7)
Edirimanne W, Woo CW, Siao YL, Rerce GN, Xie JY, OK. 2007. Homocysteine stimulates NADPH oxidase‑mediated superoxide production leading to endothelial dysfunction in rats. Can JPhysiol Pharmacol 85: 1236‑1247.8)
Munday R. 1989.Toxicity
ofthiols and disulphides: Involvement offree‑radical species.Free Radic BiolMed 7: 659‑673.
9)
Heinecke JW, Rosen H, Suzuki LA, Chait A. 1987. The role of sulfur‑containing amino acid in superoxide production and modificantion of lowdensity
1ipoprotein by arterial smooth muscle cells. JBiol chem 262: 10098‑10103.10)
Parthasarathy S, Wieland E, Steinberg D. 1989. A role for endothelial cell lipoxygenase in the oxidative modificantion of lowdensity
1ipoprotein.Proc Natl Acad Sci USA 86:1046‑1050.
60
ll)
Prasad K. 1999. HomocysteLine, a risk factor fTorcardiovascular disease.IntJofAngiol
8:76‑86.
12)
Alan L, Miller ND. 1996. Cardiovascular disease‑toward a unified approach. AltMedRev 3:132‑147.13)
Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.Circulation 104: 2673‑2678.
14)
Bellamy MF, McDowell IF, Ramsey MW, Brownlee M, Bones C, Newcombe RG, LewisMJ. 1 998. Hyperhomocysteinemia after an oral methionine load acutely impairs endothelia function in healthy adults. Circulation 98: 1 848‑1 852.
15) Mujumdar
VS, Am GM, Tragi SC. 2001. Induction of oxidative stress byhomocyst(e)ine
impairs endothelial function. J Cell Biochem 82: 491‑500.
16)
Tyagi SC. 1 999.Homocyst(e)ine
and heart disease: pathophysiology of extracellular matrix. Clin Exp HJPertenS 21 : 181‑198.1
7)
Stipanuk MH. 2004. Sulfur amino acid metabolism: pathways fTorproduction and removal df homocysteine and cysteine. Ann Rev Nutr 24: 539‑577.18)
Engbersen AM, Franken DG, Boers GH, Stevens EM,Trijbels
FJ, Blom HJ. 1995.Thermolabile 5,10‑methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am JHum Genet 56: 142‑150.
19)
Yap S, Naughten ER, Wilcken B, Wilcken DE, Boers GH. 2000. Vascular complicationsof severe hyperhomocysteinemia inpatients with homocystinuria due to cystathionine
P‑synthase
deficiency :effects of homocysteine‑lowering therapy. Semin mromb Hemost 26: 335‑340.20)
Setoue M, Ohuchi S, Morita T, Sugiyama K. 2008. Choline deprivation induces hyperhomocysteinemia in rats fed low methionine diets. J Nutr Sci Vitaminol S4:483‑490.
21)
Craig SAC. 2004. Betaine in human nutrition. Am JClin Nutr 80: 539̲649.22)
Ueland PM. 201 1.Choline and betaine inhealth and disease.JInheritMetab Dis 34:3‑15.
23)
Schwahn BC, Wendel U, Lussier‑Cacan S, Mar MH, Zeisel SH, Leclerc D, Castro C, Garrow TA, Rozen R. Effects ofbetaine in amurine model ofmild cystathionineP
‑synthase deficiency. Metabolism 53: 594‑599.
24)
Schwahn BC, Laryea MD, Chen Z, Melnyk S, Pogribny I, Garrow T, James SJ, RozenR. Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem J382: 83 1‑840.
25)
Yagisawa M, Doi Y, Uenohara T, Toda M, Shigematsu N, Nakata R. 2006. Betaine supplementation suppresses plasma homocysteine level elevation induced by fTolate deficiency in rats. Nutr Res‑26: 266‑270.26) Yagisiwa
M, Shigematsu N, Nakata R. 2006. Effects of chronic betaine ingestion onmethionine‑loading induced plasma homocysteine elevation in rats. JNutr Sci Vitaminol 52: 194‑199.
27)
Setoue M, Ohuchi S, Morita T,Sugiyama
K. 2008. Hyperhomocysteinemia induced by guanidinoacetic acid is effectively suppressed by choline and betaine in rats. Biosci Biotechnol Biochem 72: 1696‑1703.28)
Finkelstein JD, Martin JJ, Harris BJ, Kyle WE. 1983. Regulation of hepatic betaine‑homocysteine methyltransfTerase by dietary betaine. JNutr 113 :5 19‑521.29)
Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. 1999. The effect of folic acid fortification on plasma folate and total homocysteine concentration. N Engl JMed 340: l449‑1454.30)
Jungers P, Joly D, Massy Z, Chauveau P, Nguyen AT, Aupetit J, Chadefaux B. l999.Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients. Nephrol Dial Transplant 14: 2903‑?̲906.
31)
Riddell LJ, Chisholm A, Williams S, Mann JI. 2000. Dietary strategies for lowering homocysteine concentrations. Am J Clin Nutr 71: 1448‑1454.62
32)
Rydlewicz A, Simpson JA, Taylor RJ, Bond CM, Golden MH. 2002. The effect of folic acid supplementation on plasma homocysteine in an elderly population.Q
J Med 95:27‑35.
33)
van Oort FVA, Melse‑Boonstra AM, Brouwer IA, Clarke R, West CE, Katan MB, Verhoef P. 2003. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose‑response study. Am J Clin Nutr 77.. l318‑1323.34)
Lamers Y, Prinz‑Langenohl R, Moser R, Pietrzik K. 2004. Supplementation with[6S]‑5‑methyltetrahydrofolate
or folic acid equally reduces plasma total homocysteine concentrations in healthy women. Am J Clin Nutr 79: 473‑478.35)
Woo CW, Prathapasinghe GA, Siow YL, 0 K. 2006. Hyperhomocysteinemia induces liverinjury
in rats: protective effect of folic acid supplementation. Biochim Biophys Acta 1762:656‑665.36)
Leea
Rim HJ, Chang N. 2004. Effects of dietaryfrolicacid and supplementation on cerebrovascular endothelial dysfunction in rats with induced hyperhomocysteinemia.Brain Res 996: 139‑147.
37)
Wagner C. 1982. Cellular folate binding proteins; function and significance. Annu Rev Nutr 2: 229‑248.38)
Finkelstein JD, Harris BJ, Kyle WE. 1972. Methionine metabolism in mammals: kinetic study of betaine‑homocysteine methyltransfTerase. Arch Biochem Biophys 153 :320‑324.39) Pajares
MA, Perez‑Sala D. 2006. Betaine homocysteine S‑methyltransferase:just
aregulator of homocysteine metabolism? Cell Mol
Llfe
Sci 63: 2792‑2803.40)
Allen RH, Stabler SB, Lindenbaum J. 1993. Serum betaine, N,N‑dimethylglycine and N‑methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolism. Metabolism 42: 1448‑1460.41)
Allen N, Stabler SB, Savage DG, Lindenbaum J. 1993. Metabolic abnormalities in cobalamin(vitaminB.2) and
I.late deflCiency. FASEB J7: 1344‑1353.42)
Davis SR, Stacpoole PW, Williamson I, Kick LS,Quinlivan
EP, Coats BS, Shane B,Bailev LB, Gregoy
I
JF. 2004. Tracer‑derived total and folate‑dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one‑carbon donor. Am J Physiol Endocrinol Metab 286: E272‑E279.43)
Miller JW, Nadeau MR, Smith J, Selhub J. 1994. Folate‑deficiency‑inducedhomocysteinaemia inrats: disruption of S‑adenosylmethionine' s co‑ordinate regulation of homocysteine metabolism. Biochem J298: 415‑419.
44)
Dayal S, Lentz SR. 2008. Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 28: 1 596‑1605.45)
Finkelstein JD, Kyle WE, Martin JL, Pick AM. 1975. Activation of cystathionine synthase by adenosylmethionine and adenosylethionine. Biochem Biophys Res Commun 66:81‑87.46)
Finkelstein JD, Martin JJ. 1986. Methionine metabolism in mammals: adaptation to methionine excess. JBiol Chem 261: 1582‑1587.47)
Williams KT, Garrow TA, Schalinske KL. 2008. Type Idiabetes leads to tissue‑specific DNA hypomethylation in male rats. JNutr 138: 2064‑2069.48)
McGregor DO, Dellow WJ, Lever M, George PM, Robson RA, Chambers ST. 2001.Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations. Kidney tnt 59: 2267‑2272.
49)
Walzem RL, Clifford AJ. 1988. Folate deficiency in rats fred diets containing free amino acids or intactproteins. JNutr 118: 1089‑1096.50)
VerhoefP, van Vliet T, Katan MB. 2005. A high‑protein diet increases postprandial butnot fasting plasma total homocysteine concentrations: a dietary controlled, crossover trial in healthy volunteers. Am J Clin Nub. 82: 553‑558.
51)
Folch J, Lees M, Sloane‑Stanley GH. 1957. A simple method fTor the isolation and purification oftotal lipides from animal tissues. JBiol Chem 226: 497‑509.52)
Durand P, Fortin LJ, Lussier‑Cacan S, Davignon J,Blache D. 1996.Hyperhomocysteinemia
inddced
by folic acid derlCiency and methionine load ‑64
applications of a modified IVLC method. Clin Chim Acta 252: 83‑93.
53)
Cook RJ, Horne DW, Wagner C. 1989. Effect of dietary methyl group deficiency onone‑carbon metabolism inrats. JNuh. 119: 612‑617.
54)
Shimoda M. 1992. Simultaneous determination of tetrahydrofTolateandN5‑methylterahydrofolate in pig plasma by high‑performance liquid chromatography with electrochemical detection. J VetMed Sci 54: 249‑253.
55)
Laryea MD, Steinhagen F, Pawliczek S, Wendel U. 1998. Simple method for the routine determination ofbetaine and N,N‑dimethylglycine in blood and urine. Clin Chem 44:1937‑1941.
56)
LHuang L, Zhang J,Hayaka&a
T, Tsuge H. 2001. Assays.f me.hylenetet,ahyd,.I.1a.ereductase and methionine synthase activities by monitoring 5‑methyltetrahydrofolate and tetrahydrofol ate using high‑performance liquid chromatography with fluorescence
detection. AnalBiochem 299: 253‑259.
57)
Finkelstein JD, Mudd SE. 1967. Trans‑sulfuration in mammals. The methionine‑sparing effect ofcystine. JBiol Chem 242: 873‑880.58)
Mudd SH, Finkelstein JD, Irreverre F, Laster L. 1965. Transsulfuration in mammals.Mcroassay and tissue distributionsof three enzymes of the pathway. JBiol Chem 240..
4382‑4392.
59)
Einarsson S, Josefsson B, Lagerkvist S. 1983. Determination of amino acids with 9‑nuorenylmethyl chlorofTormate and reversed‑phase high‑performance liquid chromatography. J Chromatogr 282: 609‑6 1 8.60)
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. JBiol Chem 193: 265‑275.61)
Moat SJ, Lang D, McDowell IFW, Clarke ZL, Madhavan AK, Lewis MJ, Goodfellow J.2004. Folate, homocysteine, endothelial function and cardiovascular disease. JNuir Biochem 15: 64‑79.
62)
Okawa H, Morita T,Sugiyama
K. 2008. Effect of dietary soybean protein level on theplasma homocysteine concentration in rats. Biosci Biotechnol Biochem 72: 1607‑ 1610.
63)
Ohuchi S, Matsumoto Y, Mo‑rita T, Sugiyama K. 2009. High casein diet decreases plasma homocysteine concentration inrats. JNutr Sci Vitaminol 55: 22‑30.64)
Ohuchi S, Matsumoto Y, Morita T, Sugiyama K. 2008: High‑casein diet suppresses guanidinoacetic acid‑induced hyperhomocysteinemia and potentiates thehypohomocysteinemic effbct of serine inrats. Biosci Biotechnol Biochem 72 :
3258‑3264.
65)
Kawakami Y, Ohuchi S, Morita Y, Sugiyama K. 2009: Hypohomocysteinemic effect of cysteine is associated with increased plasma cysteine concentration inrats fred diets low in protein and methionine levels. JNutr Sci Vitaminol 55: 66‑74.66)
Kim Y, MillerJW, da Costa K, Nadeau M, Smith D, SelhuD J, Zeisel SH, Mason JB.1994. Severe folate deficiency causes secondary depletion of choline and phosphocholine in rat liver. JNutr 124: 2197‑2203.
67)
LeeKit
Cava M, Amiri P, Ottoboni T, Lindquist m. 1992. Betaine:homocysteine methyltransferase from rat liver: purification and inhibitionby a boronic acid substrate analog. Arch Biochem Biophys 292: 77‑86.68)
Zeisel SH. 1990. Choline deficiency. JNutr Biochem 1: 332‑349.69) Tijburg
LBM, Geelen MJH, van Golde LMG. 1989. Regulation of the biosynthesis of triacylglycerol, phosphatidylcholine and phosphatidylethanolamine inthe liver.Biochim BiophysActa lOO4:I 1‑19
70)
Pelech SL, Vance DE. 1984. Regulation of phosphatidylcholine biosynthesis. Biochim BiophysActa 779: 217‑251.71)
Yao Z, Vance DE. 1988. The active synthesis of phosphatidylcholine is required for very low den̲sity lipoprotein̲secretion from rat hepatocytes. JBiol Chem 263:2998‑3004.
72)
Song F,Poljak
A, Smythe GA, Sachdev P. 2009. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev 61: 69‑80.66
73)
Graham IM, 0'Callaghan P. 2002. Vitamins, homocysteine and cardiovascular risk.Cardiovasc Drugs Ther 16: 383‑389.
74)
Ohuchi S, Morita T, Mori M., Sugiyama K. 2009. Hepatic cystathionine a‑synthase activity does not increase in response to methionine supplementation in rats fed a low casein diet: association with plasma homocysteine concentration. J Nutr Sci Vitaminol55: l78‑l85.
75)
Zeisel SH, Zola T, daCosta KA, Pomfret EA. 1989. Effect of choline deficiency ons‑adenosylmethionine and methionine concentrations in rat liver. Biochem J 259:
725‑729.
76)
Kim YI. 2003. Role of folate in colon cancer development and progression. JNutr 133:373 1S‑3739S.
77)
Kimura H, Nakagawa H.19j1.
Studies on cystathionine synthetase characteristics of purified rat liver enzyme. JBiochem 69: 71 1‑723.78)
Finkelstein JD, Kyle WE, Harris BJ. 1971. Methionine metabolism in mammals.Regulation of homocysteine methyltransferases in rat tissue. Arch Biochem Biophys 146:
84‑92.
79)
Stead LM, Au KP, Jacobs RIJ, Brosnan ME, Brosnan JT. 200l. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine andguanidinoacetate. Am J Physiol Endocrinol Metab 281: ElO95‑E1 100.
80)
Fukada S, Setoue M, Morita T, Sugiyama K. 2006. Dietary eritadenine suppresses guanidinoacetic acid‑induce'd hyperhomocysteinemia in rats. J Nutr 136: 2797‑2802.81)
Yamada K, Tobimatsu T, Kawata T, Wada M, Maekawa A, Toraya T. 1997.Purification and some properties of cobalamin‑dependent methionine synthase from rat liver. JNutr Sci Vitaminol 43: 177‑186.
82)
Ueland PM, Helland S, Broch OJ, Schanche JS. 1984. Homocysteine in tissues of themouse and rat. JBiol Chem 259: 2360‑2364.